Dimethyl fumarate titration for the systemic treatment of moderate-to-severe plaque psoriasis

BACKGROUND: Dimethyl fumarate (DMF) is an oral systemic agent approved for the treatment of moderate-to-severe psoriasis vulgaris. It has a favourable tolerability profile, but it is associated with a high incidence of mild and reversible adverse events. The aim of the article is to describe a clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Malara, Giovanna, Fabbrocini, Gabriella, Trifirò, Caterina, Burlando, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177959/
https://www.ncbi.nlm.nih.gov/pubmed/34122590
http://dx.doi.org/10.7573/dic.2020-12-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177959/
https://www.ncbi.nlm.nih.gov/pubmed/34122590
http://dx.doi.org/10.7573/dic.2020-12-4

Ejemplares similares